Biotech | April 04, 2025
Wacker collaborates with RNAV8 Bio to enhance mRNA therapeutics development
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
Positions Curium as leading manufacturer of Lu-177 isotope
This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Subscribe To Our Newsletter & Stay Updated
